Amsterdam, September 3, 2014 - Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch of open access journal: Analytical Chemistry Research.
Published as a quarterly journal and adding to Elsevier's expanding Analytical Chemistry portfolio of journals, Analytical Chemistry Research will publish papers detailing fundamental research on all aspects of analytical theory and methodology. Themes include innovative instrumental, chemical and biological approaches, detectors and sensors, sample treatment methods and data treatment.
"This new journal will be devoted to the publication of high quality research in analytical science and will especially be concerned with the analytical applications of novel technologies, and the evaluation of these applications," said Editor-in-Chief, Professor Alan Townshend, University of Hull, UK. "I am delighted to have been invited to be the first Editor-in-Chief of this new journal and I look forward to working with Elsevier, the Editorial Advisory Board and the wider analytical community."
Richard Newell, Publisher, Analytical Chemistry at Elsevier added, "As publisher of this new journal I am very proud to be able to respond to the growing demand for choice in open access publishing from our authors by offering them Analytical Chemistry Research. I am confident it is a valuable addition to the extensive range of existing publishing options we are pleased to offer to the analytical community."
All articles published in the first issue are available on ScienceDirect:
For more information about the journal or to submit an article, go to:
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+31 20 485 3506